High demand has created a market for compounded versions of the drug best known as Ozemic or Wegovy, but doctors and the FDA ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

WeightWatchers' CEO of roughly two years, Sima Sistani, is out. She helped push the company into the white-hot weight-loss ...

Shares of WeightWatchers (WW) are climbing after the company announced a new GLP-1 medication starting at $129 as it seeks to ...

COMMENT: As a binge eater, Charlotte Cripps thought the slimming wonder drug would offer a miracle cure for her cravings. She ...

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

WW International (NASDAQ:WW), more commonly known as WeightWatchers, will now offer compounded semaglutide to its ...

which prescribes weight-loss drugs like Ozempic and Wegovy. "What we do best is help people with weight management. That is the anchor," Sistani told CNN in November. "I think we have to be true ...

My recent work focusing on Latino voters in Arizona has shown me how crucial independent journalism is in giving voice to underrepresented communities. Your support is what allows us to tell these ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

The rise of treatments such as Ozempic and Wegovy has hit the company's popularity in recent years. Last year it announced that multi-million-dollar celebrity investor Oprah Winfrey would be ...

Under Sistani, the 61-year-old company bought a telehealth platform that connected patients with doctors who can prescribe weight-loss and diabetes drugs, including Ozempic and Wegovy ...